Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment

NCT05405270 is registered in ClinicalTrials.gov with Catharina Ziekenhuis Eindhoven as lead sponsor.

NCT NCT05405270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05405270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Lead sponsor
Catharina Ziekenhuis Eindhoven
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2022
Completion date
December 31, 2026
Enrollment
410 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cervical high grade squamous intraepithelial lesion, cervical intraepithelial neoplasia, cervical intraepithelial neoplasia grade 2/3, cin 2/3